Blitz F16-83 GmbH to launch takeover offer for Epigenomics AG
(WorldNews Germany)

April 26, 2017- Epigenomics AG (FSE: ECX; OTCQX: EPGNY) (`Epigenomics` or `Company`), Cathay Fortune International Company Limited (`CFIC`) and Blitz F16-83 GmbH (in the future Summit Hero Holding GmbH, `Bidder`), a subsidiary of CFIC, have tonight entered into a business combination agreement (`BCA`) regarding the takeover of Epigenomics by the Bidder. Other than by CFIC, the Bidder will also be indirectly owned by the largest current shareholder of Epigenomics, Biochain, the strategic partner of Epigenomics and a subsidiary of Team Curis Group. Pursuant to the BCA, the Bidder has agreed to launch a voluntary public takeover offer pursuant to the German Takeover Act (Wertpapiererwerbs- und...